Three-day Trade Shows on Laboratory Technology and Pharma – Machinery Segments Kicks off at Hyderabad

• Analytica Anacon India, India Lab Expo, and Pharma Pro & Pack Expo 2022 commence
• Pharma compliance is very important and top priority for companies, the ramifications of non compliance is a costly affair: Madan Mohan Reddy, Director, Aurobindo Pharma
• Indian pharma industry to touch US$ 130 billion by 2030 and become the leading provider of medicines to the world: Sudarshan Jain, Secretary General, Indian Pharmaceutical Alliance (IPA)

Hyderabad, India’s pharma hub Hyderabad is to witness the largest gathering in South India of industry experts, leading manufacturers, buyers’ community, policy advisors, and all other stakeholders in the laboratory technology and pharma machinery segment over three days starting today. Three concurrent trade shows viz., analytic Anacon India, India Lab Expo and Pharma Pro & Pack Expo are to be held at Hitex Exhibition Centre, Hyderabad. The trade shows are jointly organised by Indian Pharma Machinery Manufacturers Association (IPMMA), Indian Analytical Instruments Association (IAIA) and Messe Muenchen. About 400 plus suppliers will be showcasing 5000 plus products in exhibition space of nearly 18,000 sq.m. with 1100 plus delegates. The trade show was inaugurated by tree plantation by dignitaries Madan Mohan Reddy, Director – Aurobindo Pharma and others. The inaugural session was also attended by Ravi Uday Bhaskar, Director General, Pharmexcil; Sudarshan Jain, Secretary General, Indian Pharmaceutical Alliance (IPA); Dr. Viranchi Shah, National President, Indian Drug Manufacturers Association (IDMA); Chakravarthi AVPS, Global Ambassador, World Packaging Organisation; Armin Wittman, Exhibition Director, Messe Muenchen GmbH; Shesul Sheth, Vice President, Indian Pharma Machinery Manufacturers Association (IPMMA) and Gautam Rajan, President, Indian Analytical Instruments Association (IAIA). The Indian pharmaceutical industry is the third largest in the world, and it has seen a record growth of about 11 percent in FY22, mainly driven by emerging and domestic markets. Trade shows like this after the gap generated by COVID pandemic are a great opportunity for the industry. The three-day trade show is expected to see footfall of over 15,000 people. The three days will be marked by knowledge-rich conferences, focused buyer-seller meetings and an opportunity to network.

Analytica Anacon India showcases analytical instruments, laboratory technologies and equipments, ancillaries and more. India Lab Expo showcases chromatographs, spectroscopes, microscopes and imaging, bioinformatics, medicine and diagnostics, etc. and related products. pharma Pro & Pack Expo 2022 showcases processing machineries, packaging machineries, etc. Few of the exhibitors include Glatt Systems, Parle Global, DEC Bectochem, Anish Pharma, Accupack Engineering, Snowbell Machines, Agilent, Shimadzu, Thermo Fisher Scientific, Merck, Electrolab, etc.

Speaking on the sidelines of the inaugural, Madan Mohan Reddy, Director, Aurobindo Pharma said, “The exhibitions are an advantage for the pharma industry in Hyderabad and entire India. India is a big player in the pharma industry with a lot of scope for improvement with a lot of generic business and a lot of patents expiring. Indian manufacturers are having excellent technology and domestic manufacturers are able to meet all Good Manufacturing Practices (GMP) compliance and international regulatory requirements. Pharma compliance is very important and top priority for companies, the ramifications of non compliance with regulatory affairs is a costly affair for the manufacturers,” he said.

Sudarshan Jain, Secretary General, Indian Pharmaceutical Alliance (IPA) said that “With India becoming the fifth largest economy in the world this is the time for Indian industry to make a difference in the world. The Indian pharma industry sector currently is valued at US$ 49 billion and is the third largest in the world. It is expected to grow to US$ 130 billion by 2030 and become the leading provider of medicines to the world. Our medicines are supplied to over 200 countries in the world, he said. He stressed on innovation, self-dependence, diversifying the export market and building capacity for the Indian industry to be future-ready.”

Dr. Viranchi Shah, National President, Indian Drug Manufacturers Association (IDMA) addressing a media gathering said that “Production Linked Incentive Schemes (PLIs) and cluster manufacturing are contributing to the pharma sector’s growth. India is aspiring to be No.1 in the next 25 years, he declared. PLIs and cluster manufacturing will reduce our dependence on imported medicines, he opined. When India completes its 100 years of independence, India in 2047 will be a US$ 500 billion industry. PLI 1.0 and 2.0 are vital for India to achieve this goal, he said. The IDMA is working closely with the Government of India on PLI 2.0. Large parts of imported medicine and equipment will be manufactured locally, decreasing dependence on imports and giving healthcare security to India. India is moving from being a generic manufacturing giant to value addition. Innovation, Technology and Entrepreneurship will drive India towards this,” he opined.

Ravi Uday Bhaskar, Director General, Pharmexcil said that, “The future for the Indian pharma and allied industries is bright but there are challenges too. Any export will depend on the importing policies of other countries. There is a need to streamline the industry especially in terms of regulations. Different countries have different regulations. Industry-regulator understanding is important for growth. Common regulatory standards like those in the European Union need to be worked out globally so that it is helpful for the pharma industry,” he said.

“The Indian Lab tech industry is valued at approximately US$ 1.3 billion of which 60-65 percent is pharma related. Analytical instruments industry is the pillar for the Indian pharma industry to grow,” said Gautam Rajan, President, Indian Analytical Instruments Association (IAIA). Innovation and quality are vital in the analytical instruments industry for Indian pharma industry growth, he said.

Chakravarthi AVPS, Global Ambassador, World Packaging Organisation said that Packing will be your second physician. He stressed on the need for quality packaging. It is the responsibility of everyone in the industry for quality medicine to reach a patient. Medical packaging is crucial and is vital to protect the efficacy of the medicine till it reaches the patient, he said in a presentation.

After a successful run in Mumbai earlier this year, analytica Anacon India and India Lab Expo 2022 are back again along with one of the largest pharma machinery shows in South India -Pharma Pro & Pack Expo 2022. Messe Munchen is one of the leading exhibition organisers worldwide. It organises trade fairs in China, India, Brazil, Africa, Turkey, and Vietnam. Evolving manufacturing capabilities with technology upgrades are important for the industry to thrive. Our trade shows deliver insights, opportunities and network for the industry, said Armin Wittman, Exhibition Director, Messe Muenchen GmbH, Germany.

The three concurrent trade shows bringing decision makers, industry stakeholders, and policymakers, leading manufacturers and buyers of pharma machinery, analytical equipment, and laboratory technology will conclude on Sunday evening i.e. 17th September.

Newsvoir